Global Blood Therapeutics Inc (GBT)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

181 OYSTER POINT BLVD SOUTH SAN FRANCISCO, CA 94080

Global Blood Therapeutics (GBT) is a biopharmaceutical company dedicated to the discovery, development, and delivery of life-changing treatments that provide hope to underserved patient communities. Founded in 2011, GBT is delivering on its goal to transform the treatment and care of sickle cell disease (SCD), a lifelong, devastating inherited blood disorder. The company has introduced Oxbryta® (voxelotor) tablets, the first FDA-approved treatment that directly inhibits sickle hemoglobin polymerization, the root cause of red blood cell sickling in SCD. GBT is also advancing its pipeline program in SCD with inclacumab, a P-selectin inhibitor in development to address pain crises associated with the disease, and GBT021601 (GBT601), the company's next generation hemoglobin S polymerization inhibitor. In addition, GBT's drug discovery teams are working on new targets to develop the next wave of treatments for SCD.

Data as of 2021-06-19 12:25:15 -0400
Market Cap2.281 Billion Shares Outstanding62.267 Million Avg 30-day Volume890.041 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-8.04 Enterprise Value
Total Cash Current Debt Gross Profit
BETA0.81995 52-week High/Low76.27 / 34.65 Next Earnings Date2021-08-04 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from GBT instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 5 5 0.0% 3 (0.18%) 3 (0.17%) 0.0%
Funds Holding: 209 227 -7.93% 62 (3.64%) 74 (4.29%) -16.22%
13F shares: 65.853 Million 64.41 Million 2.24% 20.887 Million 17.235 Million 21.19%
% Ownership 33.6039 27.8899 20.49%
New Positions: 23 55 -58.18% 7 26 -73.08%
Increased Positions 61 85 -28.24% 21 21 0.0%
Closed Positions 39 55 -29.09% 19 19 0.0%
Reduced Positions 96 61 57.38% 25 22 13.64%
Total Calls 495.82 Thousand 935.071 Thousand -46.98% 281 Thousand 538.313 Thousand -47.8%
Total Puts 512.825 Thousand 1.227 Million -58.2% 135.6 Thousand 420.1 Thousand -67.72%
PUT/CALL Ratio 1.03 1.31 -21.37% 0.48 0.78 -38.46%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding GBT (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding GBT BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

500 total shares from 1 transactions

Open Market Sells (S)

2.7 Thousand total shares from 2 transactions

Exercise Derivative Conversion (M)

24.3 Thousand total shares from 8 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

PATRICK DEVAL L

  • Director
14,637 2021-06-17 2

BROWN WILLIE L. JR.

  • Director
48,465 2021-06-17 1

PERRY MARK L

  • Director
43,465 2021-06-17 1

PIZZO PHILIP A.

  • Director
23,809 2021-06-17 1

MORRISON SCOTT W

  • Director
17,037 2021-06-17 1

PIERCE GLENN

  • Director
32,037 2021-06-17 2

YARNO WENDY L

  • Director
17,037 2021-06-17 1

SVORONOS DAWN

  • Director
18,177 2021-06-17 1

THOMPSON ALEXIS A.

  • Director
2,320 2021-06-17 3

SMITH-WHITLEY KIM SEE REMARKS

  • Officer
65,960 2021-06-01 3

FINK ERIC CHIEF HUMAN RESOURCES OFFICER

  • Officer
5,161 2021-05-10 7

JOHNSON DAVID LEE CHIEF COMMERCIAL OFFICER

  • Officer
39,019 2021-04-01 5

CHOI JUNG SEE REMARKS

  • Officer
262,931 2021-03-01 3

LOVE TED W PRESIDENT AND CEO

  • Officer
  • Director
1,086,800 2021-03-01 3

FARROW JEFFREY S CHIEF FINANCIAL OFFICER

  • Officer
60,841 2021-03-01 4

SUVARI TRICIA BORGA CHIEF LEGAL OFFICER

  • Officer
80,406 2021-03-01 3

CATHERS BRIAN EDWIN CHIEF SCIENTIFIC OFFICER

  • Officer
75,820 2021-03-01 5

CALHOUN LESLEY ANN SEE REMARKS

  • Officer
154 2020-05-26 0

LEHRER-GRAIWER JOSHUA CHIEF MEDICAL OFFICER

  • Officer
2,595 2020-03-05 0

HOMCY CHARLES J

  • Director
0 2018-06-20 0

PERCEPTIVE ADVISORS LLC

PERCEPTIVE LIFE SCIENCES MASTER FUND LTD

EDELMAN JOSEPH

  • FORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNER
No longer subject to file 2018-03-08 0

SHAM HING SEE REMARKS

  • Officer
98,215 2018-03-07 0

RADOVICH PETER SEE REMARKS

  • Officer
8,833 2018-02-14 0

THIRD ROCK VENTURES II, L.P.

THIRD ROCK VENTURES GP II, L.P.

TRV GP II, LLC

LEVIN MARK J

TEPPER ROBERT I

STARR KEVIN P

  • 10% Owner
No longer subject to file 2017-06-14 0

TEPPER ROBERT I

  • 10% Owner
4,990,677 2017-04-06 0

THIRD ROCK VENTURES II, L.P.

THIRD ROCK VENTURES GP II, L.P.

TRV GP II, LLC

THIRD ROCK VENTURES III, L.P.

THIRD ROCK VENTURES GP III, L.P.

TRV GP III, LLC

LEVIN MARK J

TEPPER ROBERT I

STARR KEVIN P

  • 10% Owner
420,253 2017-03-02 0

STARR KEVIN P

  • 10% Owner
8,843,448 2016-12-16 0

RAMOS ELEANOR CHIEF MEDICAL OFFICER

  • Officer
0 2016-09-29 0

BONNEY MICHAEL W

  • Director
0 2016-06-16 0

SCHEMBRI JOHN SEE REMARKS

  • Officer
0 2016-03-10 0

THIRD ROCK VENTURES III, L.P.

THIRD ROCK VENTURES GP III, L.P.

TRV GP III, LLC

LEVIN MARK J

TEPPER ROBERT I

  • 10% Owner
2,285,713 2015-08-17 0

THIRD ROCK VENTURES II, L.P.

THIRD ROCK VENTURES GP II, L.P.

TRV GP II, LLC

LEVIN MARK J

TEPPER ROBERT I

  • 10% Owner
12,475,191 2015-08-17 0

THIRD ROCK VENTURES II, L.P.

THIRD ROCK VENTURES GP II, L.P.

TRV GP II, LLC

THIRD ROCK VENTURES III, L.P.

THIRD ROCK VENTURES GP III, L.P.

TRV GP III, LLC

LEVIN MARK J

TEPPER ROBERT I

  • 10% Owner
571,428 2015-08-11 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

PIZZO PHILIP A. - Director

2021-06-21 16:15:42 -0400 2021-06-18 S 1,065 $36.54 d 6,772 direct yes

SVORONOS DAWN - Director

2021-06-21 16:31:30 -0400 2021-06-18 S 1,609 $36.54 d 3,684 direct yes

PATRICK DEVAL L - Director

2021-06-21 16:15:43 -0400 2021-06-17 M 3,037 a 5,437 direct

SVORONOS DAWN - Director

2021-06-21 16:31:30 -0400 2021-06-17 M 3,037 d 0 direct

BROWN WILLIE L. JR. - Director

2021-06-21 16:18:51 -0400 2021-06-17 A 3,600 a 3,600 direct

BROWN WILLIE L. JR. - Director

2021-06-21 16:18:51 -0400 2021-06-17 M 3,037 a 39,265 direct

PERRY MARK L - Director

2021-06-21 16:27:25 -0400 2021-06-17 M 3,037 d 0 direct

THOMPSON ALEXIS A. - Director

2021-06-21 16:23:36 -0400 2021-06-17 A 1,412 a 1,412 direct

PIERCE GLENN - Director

2021-06-21 16:24:25 -0400 2021-06-17 M 3,037 d 0 direct

MORRISON SCOTT W - Director

2021-06-21 16:14:44 -0400 2021-06-17 A 5,600 a 5,600 direct

PIZZO PHILIP A. - Director

2021-06-21 16:15:42 -0400 2021-06-17 A 3,600 a 3,600 direct

YARNO WENDY L - Director

2021-06-21 16:11:50 -0400 2021-06-17 A 3,600 a 3,600 direct

YARNO WENDY L - Director

2021-06-21 16:11:50 -0400 2021-06-17 M 3,037 a 7,837 direct

PATRICK DEVAL L - Director

2021-06-21 16:15:43 -0400 2021-06-17 A 5,600 a 5,600 direct

SVORONOS DAWN - Director

2021-06-21 16:31:30 -0400 2021-06-17 A 3,600 a 3,600 direct

BROWN WILLIE L. JR. - Director

2021-06-21 16:18:51 -0400 2021-06-17 A 5,600 a 5,600 direct

PERRY MARK L - Director

2021-06-21 16:27:25 -0400 2021-06-17 A 3,600 a 3,600 direct

PERRY MARK L - Director

2021-06-21 16:27:25 -0400 2021-06-17 M 3,037 a 34,265 direct

PIERCE GLENN - Director

2021-06-21 16:24:25 -0400 2021-06-17 A 3,600 a 3,600 direct

PIERCE GLENN - Director

2021-06-21 16:24:25 -0400 2021-06-17 M 3,037 a 22,837 direct

MORRISON SCOTT W - Director

2021-06-21 16:14:44 -0400 2021-06-17 M 3,037 d 0 direct

PIZZO PHILIP A. - Director

2021-06-21 16:15:42 -0400 2021-06-17 A 5,600 a 5,600 direct

YARNO WENDY L - Director

2021-06-21 16:11:50 -0400 2021-06-17 A 5,600 a 5,600 direct

PIZZO PHILIP A. - Director

2021-06-21 16:15:42 -0400 2021-06-17 M 3,037 a 7,837 direct

PATRICK DEVAL L - Director

2021-06-21 16:15:43 -0400 2021-06-17 M 3,037 d 0 direct

SVORONOS DAWN - Director

2021-06-21 16:31:30 -0400 2021-06-17 A 5,600 a 5,600 direct

SVORONOS DAWN - Director

2021-06-21 16:31:30 -0400 2021-06-17 M 3,037 a 5,293 direct

BROWN WILLIE L. JR. - Director

2021-06-21 16:18:51 -0400 2021-06-17 M 3,037 d 0 direct

PERRY MARK L - Director

2021-06-21 16:27:25 -0400 2021-06-17 A 5,600 a 5,600 direct

THOMPSON ALEXIS A. - Director

2021-06-21 16:23:36 -0400 2021-06-17 A 908 a 908 direct

PIERCE GLENN - Director

2021-06-21 16:24:25 -0400 2021-06-17 A 5,600 a 5,600 direct

MORRISON SCOTT W - Director

2021-06-21 16:14:44 -0400 2021-06-17 A 3,600 a 3,600 direct

MORRISON SCOTT W - Director

2021-06-21 16:14:44 -0400 2021-06-17 M 3,037 a 7,837 direct

PIZZO PHILIP A. - Director

2021-06-21 16:15:42 -0400 2021-06-17 M 3,037 d 0 direct

YARNO WENDY L - Director

2021-06-21 16:11:50 -0400 2021-06-17 M 3,037 d 0 direct

PATRICK DEVAL L - Director

2021-06-21 16:15:43 -0400 2021-06-17 A 3,600 a 3,600 direct

SMITH-WHITLEY KIM - Officer SEE REMARKS

2021-06-02 20:02:15 -0400 2021-06-01 A 6,300 a 6,300 direct

SMITH-WHITLEY KIM - Officer SEE REMARKS

2021-06-21 16:05:52 -0400 2021-06-01 A 42,400 a 42,400 direct

SMITH-WHITLEY KIM - Officer SEE REMARKS

2021-06-02 20:02:15 -0400 2021-06-01 A 24,160 a 24,160 direct

SMITH-WHITLEY KIM - Officer SEE REMARKS

2021-06-02 20:02:15 -0400 2021-06-01 A 35,500 a 35,500 direct

FINK ERIC - Officer CHIEF HUMAN RESOURCES OFFICER

2021-05-10 17:38:00 -0400 2021-05-10 P 500 $37.96 a 5,161 direct -3.149 -1.3231 0.0 1 -6.1657 3

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
GLOBAL BLOOD THERAPEUTICS IN GBT 2021-06-21 22:15:03 UTC -0.17 0.25 950000
GLOBAL BLOOD THERAPEUTICS IN GBT 2021-06-21 21:45:03 UTC -0.17 0.25 950000
GLOBAL BLOOD THERAPEUTICS IN GBT 2021-06-21 21:15:03 UTC -0.17 0.25 950000
GLOBAL BLOOD THERAPEUTICS IN GBT 2021-06-21 20:45:03 UTC -0.17 0.25 950000
GLOBAL BLOOD THERAPEUTICS IN GBT 2021-06-21 20:15:03 UTC -0.17 0.25 950000
GLOBAL BLOOD THERAPEUTICS IN GBT 2021-06-21 19:45:03 UTC -0.17 0.25 950000
GLOBAL BLOOD THERAPEUTICS IN GBT 2021-06-21 19:15:03 UTC -0.17 0.25 950000
GLOBAL BLOOD THERAPEUTICS IN GBT 2021-06-21 18:45:03 UTC -0.17 0.25 950000
GLOBAL BLOOD THERAPEUTICS IN GBT 2021-06-21 18:15:03 UTC -0.17 0.25 950000
GLOBAL BLOOD THERAPEUTICS IN GBT 2021-06-21 17:45:03 UTC -0.17 0.25 950000
GLOBAL BLOOD THERAPEUTICS IN GBT 2021-06-21 17:15:03 UTC -0.17 0.25 950000
GLOBAL BLOOD THERAPEUTICS IN GBT 2021-06-21 16:45:02 UTC -0.17 0.25 950000
GLOBAL BLOOD THERAPEUTICS IN GBT 2021-06-21 16:15:03 UTC -0.17 0.25 950000
GLOBAL BLOOD THERAPEUTICS IN GBT 2021-06-21 15:45:03 UTC -0.17 0.25 950000
GLOBAL BLOOD THERAPEUTICS IN GBT 2021-06-21 15:15:03 UTC -0.17 0.25 950000
GLOBAL BLOOD THERAPEUTICS IN GBT 2021-06-21 14:45:03 UTC -0.17 0.25 950000
GLOBAL BLOOD THERAPEUTICS IN GBT 2021-06-21 14:15:02 UTC -0.17 0.25 950000
GLOBAL BLOOD THERAPEUTICS IN GBT 2021-06-21 13:45:03 UTC -0.17 0.25 950000
GLOBAL BLOOD THERAPEUTICS IN GBT 2021-06-21 13:15:03 UTC -0.17 0.25 950000
GLOBAL BLOOD THERAPEUTICS IN GBT 2021-06-21 12:45:03 UTC -0.17 0.25 950000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
American Century Quantitative Equity Funds, Inc.- AC Alternatives Disciplined Long Short Fund GBT -1104.0 shares, $-87756.96 2019-12-31 N-PORT
Trust for Professional Managers- Convergence Market Neutral Fund GBT -1028.0 shares, $-64537.84 2020-08-31 N-PORT
FundVantage Trust- Gotham Master Neutral Fund GBT -18.0 shares, $-992.52 2020-09-30 N-PORT
FundVantage Trust- Gotham Index Plus All-Cap Fund GBT -1.0 shares, $-51.09 2020-03-31 N-PORT
Columbia Funds Series Trust I- Multi-Manager Directional Alternative Strategies Fund GBT -1750.0 shares, $-87710.0 2021-01-31 N-PORT
RBB Fund, Inc.- Boston Partners Long/Short Research Fund GBT -14579.0 shares, $-621065.4 2021-02-28 N-PORT
Trust for Professional Managers- Convergence Long/Short Equity Fund GBT -521.0 shares, $-22194.6 2021-02-26 N-PORT
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund GBT -2200.0 shares, $-89650.0 2021-03-31 N-PORT
FundVantage Trust- Gotham Hedged Plus Fund GBT -1191.0 shares, $-48533.25 2021-03-31 N-PORT
Prudential Investment Portfolios 12- PGIM QMA Large-Cap Core Equity Plus Fund GBT -1400.0 shares, $-57050.0 2021-03-31 N-PORT
Prudential Investment Portfolios 12- PGIM QMA Long-Short Equity Fund GBT -5500.0 shares, $-224125.0 2021-03-31 N-PORT
TIFF INVESTMENT PROGRAM- TIFF Multi-Asset Fund GBT -7685.0 shares, $-313163.75 2021-03-31 N-PORT
Advanced Series Trust- AST QMA U.S. Equity Alpha Portfolio GBT -22800.0 shares, $-929100.0 2021-03-31 N-PORT
Advanced Series Trust- AST Academic Strategies Asset Allocation Portfolio GBT -4600.0 shares, $-187450.0 2021-03-31 N-PORT
AQR Funds- AQR Alternative Risk Premia Fund GBT -5846.0 shares, $-238224.5 2021-03-31 N-PORT
AQR Funds- AQR Multi-Asset Fund GBT -1130.0 shares, $-46047.5 2021-03-31 N-PORT
JNL Series Trust- JNL/AQR Large Cap Relaxed Constraint Equity Fund GBT -9326.0 shares, $-380034.5 2021-03-31 N-PORT

Elevate your investments